Raja (Eladnani) Prince/LinkedIn
Dec 4, 2025, 02:34
Raja Prince and Team: Protein S as a Therapeutic Target
Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, posted on LinkedIn:
”I’m delighted to share our newly published review in Journal of Thrombosis and Haemostasis (JTH).
In this article, our team provides an updated and comprehensive overview of protein S as a therapeutic target, summarizing current knowledge, emerging therapeutic strategies, and key challenges in the field of hemostasis.
A big thank you to my two coauthors, Rim Diab and Anne Angelillo-Scherrer.”
Read the full article here.
Title: Protein S as a therapeutic target
Authors: Raja Prince Eladnani, Rim Diab, Anne Angelillo-Scherrer
Stay updated with Hemostasis Today.
-
Mar 10, 2026, 12:39Roberta Gualtierotti: How Do Sex and Gender Influence VTE in Patients with Cancer?
-
Mar 10, 2026, 12:39Tareq Abadl: Detecting the Hidden Risk of NAIT in the Lab
-
Mar 10, 2026, 12:36Amitabh Kulkarni: What Parents Need to Know About Iron Deficiency Anemia in Children
-
Mar 10, 2026, 12:23Bastu Odoka: The Laboratory’s Role in Preventing RhD Disease
-
Mar 10, 2026, 12:22Kalyan Roy: Rediscovering Cold-Stored Platelets in Modern Transfusion Medicine
-
Mar 10, 2026, 04:15Abdul Mannan: NK Cell ALL and the Diagnostic Challenge of a Provisional Entity:
-
Mar 9, 2026, 16:51Melanie Daniel: Exploring Bleeding Complications in Patients with LVADs
-
Mar 9, 2026, 16:30Mohamed Sikkander Abdul Razak: Recent Breakthroughs in Stem Cell Therapy for Diabetes Treatment
-
Mar 9, 2026, 16:28Augustina Isioma Ikusemoro: Is Blood Really Affordable?